SQZ Biotech raises $72M in Series C funding round
The company will use funding to bring cell therapies into clinic in oncology and autoimmune indications.
The company will use funding to bring cell therapies into clinic in oncology and autoimmune indications.
Don’t get the idea that beer is good for you, but a biotech startup is pinning it hopes on the ability of a derivative of hops, the plant that gives beer its bitter taste, to help people with diabetes lose weight and control their glucose levels. Seattle-based KinDex Pharmaceuticals recently unveiled itself with the announcement […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.